SQSTM1 Splice Site Mutation in Distal Myopathy with Rimmed Vacuoles
Authors
Affiliations
Objective: To identify the genetic etiology and characterize the clinicopathologic features of a novel distal myopathy.
Methods: We performed whole-exome sequencing on a family with an autosomal dominant distal myopathy and targeted exome sequencing in 1 patient with sporadic distal myopathy, both with rimmed vacuolar pathology. We also evaluated the pathogenicity of identified mutations using immunohistochemistry, Western blot analysis, and expression studies.
Results: Sequencing identified a likely pathogenic c.1165+1 G>A splice donor variant in SQSTM1 in the affected members of 1 family and in an unrelated patient with sporadic distal myopathy. Affected patients had late-onset distal lower extremity weakness, myopathic features on EMG, and muscle pathology demonstrating rimmed vacuoles with both TAR DNA-binding protein 43 and SQSTM1 inclusions. The c.1165+1 G>A SQSTM1 variant results in the expression of 2 alternatively spliced SQSTM1 proteins: 1 lacking the C-terminal PEST2 domain and another lacking the C-terminal ubiquitin-associated (UBA) domain, both of which have distinct patterns of cellular and skeletal muscle localization.
Conclusions: SQSTM1 is an autophagic adaptor that shuttles aggregated and ubiquitinated proteins to the autophagosome for degradation via its C-terminal UBA domain. Similar to mutations in VCP, dominantly inherited mutations in SQSTM1 are now associated with rimmed vacuolar myopathy, Paget disease of bone, amyotrophic lateral sclerosis, and frontotemporal dementia. Our data further suggest a pathogenic connection between the disparate phenotypes.
Muelas N, Carretero-Vilarroig L, Marti P, Azorin I, Frasquet M, Poyatos-Garcia J J Neurol. 2025; 272(1):97.
PMID: 39775307 DOI: 10.1007/s00415-024-12821-3.
Masuko S, Sato M, Nakamura K, Hamanaka K, Miyatake S, Inaba Y Mol Genet Genomic Med. 2024; 12(11):e70044.
PMID: 39587727 PMC: 11588856. DOI: 10.1002/mgg3.70044.
Findlay A Dis Model Mech. 2024; 17(10).
PMID: 39501809 PMC: 11574355. DOI: 10.1242/dmm.050720.
McNamara J, Parker B, Voges H, Mehdiabadi N, Bolk F, Ahmad F Nat Cardiovasc Res. 2024; 2(2):159-173.
PMID: 39196058 PMC: 11358020. DOI: 10.1038/s44161-023-00219-9.
Genome and RNA sequencing boost neuromuscular diagnoses to 62% from 34% with exome sequencing alone.
Marchant R, Bryen S, Bahlo M, Cairns A, Chao K, Corbett A Ann Clin Transl Neurol. 2024; 11(5):1250-1266.
PMID: 38544359 PMC: 11093248. DOI: 10.1002/acn3.52041.